The Latest Breaking News from David Rind

Weight-loss drugs are already dropping in price; could they go even lower?

Consumers are now able to pay roughly $500 for the drugs, which often retail at more than $1,000

The Independent UK · May 27, 2025

As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence

Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.

WEKU · May 13, 2024

An Alzheimer's drug is on the way, but getting it may still be tough. Here's why

The Food and Drug Administration is expected to grant full approval to the Alzheimer's drug lecanemab by July 6. But access to the drug may still be limited.

WEKU · Jun 26, 2023